ABSTRACT To address the issue of recovery imbalance caused by the spatial heterogeneity of haze concentration in real scenarios, this paper proposes an adaptive feature enhanced contrastive learning framework (AFE‐Dehaze). The framework achieves breakthroughs through three major collaborative mechanisms: (1) a hierarchical multi‐scale fusion architecture that combines diffusion convolution and channel attention, preserving edge textures (such as leaf veins and building contours) in thin haze areas, while semantically guiding the reconstruction of structural details in dense haze areas, improving texture retention by 18% compared to traditional U‐Net; (2) a concentration‐sensitive contrastive learning paradigm that uses pre‐trained VGG features as semantic anchors, applying pixel‐level constraints in thin haze and feature space constraints in dense haze, which reduces color distortion () by 23%, significantly outperforming methods like refusion; (3) a gradient dynamic balancing strategy that automatically adjusts the optimization direction by analyzing positive and negative sample gradient contributions, enhancing PSNR by 1.2dB and SSIM by 0.05 in non‐uniform haze scenarios. Experiments on a mixed dataset (RESIDE OTS real scenes) demonstrate that AFE‐Dehaze achieves an average PSNR of 28.7dB and SSIM of 0.91, especially improving structural similarity in dense haze areas by 9% compared to Mamba, validating its generalization capability in complex haze environments. This framework provides a solution that balances accuracy and robustness for dehazing in real scenarios such as vehicular vision and remote sensing imaging.

In this article, we propose novel structural nested models to estimate causal effects of continuous treatments based on mobile health data. To find the treatment regime which optimizes the short-term outcomes for the patients, we define the weighted lag K advantage. The optimal treatment regime is then defined to be the one which maximizes this advantage. This method imposes minimal assumptions on the data generating process. Statistical inference can also be provided for the estimated parameters. Simulation studies and an application to the Ohio type 1 diabetes dataset show that our method could provide meaningful insights for dose suggestions with mobile health data.

An individualized dose rule recommends a dose level within a continuous safe dose range based on patient level information such as physical conditions, genetic factors and medication histories. Traditionally, personalized dose finding process requires repeating clinical visits of the patient and frequent adjustments of the dosage. Thus the patient is constantly exposed to the risk of underdosing and overdosing during the process. Statistical methods for finding an optimal individualized dose rule can lower the costs and risks for patients. In this article, we propose a kernel assisted learning method for estimating the optimal individualized dose rule. The proposed methodology can also be applied to all other continuous decision-making problems. Advantages of the proposed method include robustness to model misspecification and capability of providing statistical inference for the estimated parameters. In the simulation studies, we show that this method is capable of identifying the optimal individualized dose rule and produces favorable expected outcomes in the population. Finally, we illustrate our approach using data from a warfarin dosing study for thrombosis patients.